Author:
Weber Benjamin,Lee Sau L.,Lionberger Robert,Li Bing V.,Tsong Yi,Hochhaus Guenther
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Lee SL, Adams WP, Li BV, Conner DP, Chowdhury BA, Yu LX. In vitro considerations to support bioequivalence of locally acting drugs in dry powder inhalers for lung diseases. AAPS J. 2009;11:414–23.
2. Weber B, Hochhaus G, Adams W, Lionberger R, Li B, Tsong Y, et al. A stability analysis of a modified version of the chi-square ratio statistic: implications for equivalence testing of aerodynamic particle size distribution. AAPS J. 2013;15:1–9.
3. Food and Drug Administration Center for Drug Evaluation and Research (CDER). Guidance for industry - bioavailability and bioequivalence studies for nasal aerosols and nasal sprays for local action (Draft Guidance), June 1999. http://www.fda.gov/ohrms/dockets/ac/00/backgrd/36099b1l.pdf . Accessed 13 June 2012
4. Christopher D, Adams W, Amann A, Bertha C, Byron PR, Doub W, et al. Product quality research institute evaluation of cascade impactor profiles of pharmaceutical aerosols, part 3: final report on a statistical procedure for determining equivalence. AAPS PharmSciTech. 2007;8:65–74.
5. Christopher D, Adams WP, Lee DS, Morgan B, Pan Z, Singh GJ, et al. Product quality research institute evaluation of cascade impactor profiles of pharmaceutical aerosols: part 2—evaluation of a method for determining equivalence. AAPS PharmSciTech. 2007;8:E39–48.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献